These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20920814)

  • 1. Neuromuscular complications of hepatitis A virus infection and vaccines.
    Stübgen JP
    J Neurol Sci; 2011 Jan; 300(1-2):2-8. PubMed ID: 20920814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular disorders associated with Hepatitis B vaccination.
    Stübgen JP
    J Neurol Sci; 2010 May; 292(1-2):1-4. PubMed ID: 20207367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic hepatitis C and risk for hepatitis A infection].
    Chlabicz S; Grzeszczuk A
    Przegl Epidemiol; 2001; 55(3):281-6. PubMed ID: 11761835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA
    Expert Rev Vaccines; 2008 Oct; 7(8):1141-50. PubMed ID: 18844588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP; Gregor JC; Marotta PJ
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response.
    Mariya FA; de Mello Perez R; Silva AE; Pestana JO; Ferraz ML
    Transplant Proc; 2004 Jun; 36(5):1500-1. PubMed ID: 15251370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
    Gherardi RK
    Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risks associated with hepatitis infection in patients with hepatitis C and opportunities for prophylaxis].
    Chlabicz S
    Przegl Epidemiol; 2003; 57(3):465-70. PubMed ID: 14682165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
    de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of anti-hepatitis A virus antibodies in chidren in Marrakech].
    Bouskraoui M; Bourrous M; Amine M
    Arch Pediatr; 2009 Oct; 16 Suppl 2():S132-6. PubMed ID: 19836677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.